In AFP producing gastric adenocarcinoma group, 27 patients had relapsed [84.4% (27/32)] compared with 28 in AFP non-producing gastric adenocarcinoma group [62.2% (28/45)] (p=0.029). This evidence concerns the gene AFP and gastric adenocarcinoma.